Epsilon Healthcare (FRA:9TH0) Debt-to-Equity : 0.30 (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare Debt-to-Equity?

Epsilon Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €1.54 Mil. Epsilon Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.18 Mil. Epsilon Healthcare's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €5.68 Mil. Epsilon Healthcare's debt to equity for the quarter that ended in Jun. 2023 was 0.30.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Epsilon Healthcare's Debt-to-Equity or its related term are showing as below:

FRA:9TH0' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.2 Max: 0.35
Current: 0.3

During the past 6 years, the highest Debt-to-Equity Ratio of Epsilon Healthcare was 0.35. The lowest was 0.02. And the median was 0.20.

FRA:9TH0's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.3 vs FRA:9TH0: 0.30

Epsilon Healthcare Debt-to-Equity Historical Data

The historical data trend for Epsilon Healthcare's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare Debt-to-Equity Chart

Epsilon Healthcare Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.02

0.03

0.20

0.23

0.35

Epsilon Healthcare Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Equity	Get a 7-Day Free Trial								0.20	0.23	0.28	0.35	0.30

Competitive Comparison of Epsilon Healthcare's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epsilon Healthcare's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's Debt-to-Equity falls into.

Epsilon Healthcare Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Epsilon Healthcare's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.624	+	0.413)	/	5.905
	=	0.34

Epsilon Healthcare's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.539	+	0.183)	/	5.675
	=	0.30

Epsilon Healthcare (FRA:9TH0) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Epsilon Healthcare Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Epsilon Healthcare (FRA:9TH0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (FRA:9TH0) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

EPN:Australia

Address

35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000

Website

https://www.epsilonhealthcare.com.au

Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (FRA:9TH0) Headlines

No Headlines